NCT04421248View on ClinicalTrials.gov

Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder

PHASE4RecruitingINTERVENTIONAL
Enrollment

214

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

February 1, 2026

Study Completion Date

April 1, 2026

Conditions
Attention Deficit Hyperactivity Disorder Combined
Interventions
DRUG

Methylphenidate

In ADHD participants only: blinded, randomized, placebo-controlled single dose, crossover on separate days separated by at least one week.

DRUG

Placebo

In ADHD participants only: blinded, randomized, placebo-controlled, single dose, crossover on separate days separated by at least one week.

Trial Locations (2)

21205

RECRUITING

Kennedy Krieger Institute, Baltimore

45229

RECRUITING

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
collaborator

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

OTHER

lead

Donald Gilbert, MD, MS, FAAN, FAAP

OTHER